Concomitant gut dysbiosis and defective gut barrier serve as the bridges between hypercortisolism and chronic systemic inflammation in Cushing disease

We conducted a thorough analysis using metagenomics, fecal metabolomics, and serum ELISA assays in active CD patients, incorporating in vitro experiments to explore microbiota-gut-brain axis dysregulation and its implications in CD.